SCHEMBL18654626

SCHEMBL18654626

Cc1nc2ccc(-c3ccccc3F)nn2c1C(=O)NC1=CC=CNN1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 6/20 0.37
▸ CSNK1E P49674 6/20 0.37
▸ MAP4K1 Q92918 2/20 0.34
▸ THRB P10828 1/20 0.34
▸ TGFBR1 P36897 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18654723 0.89 EPHB3 (0.40) CSNK1DCSNK1ETHRBTGFBR1LMNA
SCHEMBL18654658 0.89 EPHB3 (0.35) CSNK1DCSNK1ETGFBR1LMNAGLA
SCHEMBL18654323 0.88 NTRK1 (0.35) CSNK1DCSNK1E
SCHEMBL18655239 0.87 CSNK1D (0.38) CSNK1DCSNK1EMAP4K1TGFBR1USP2
SCHEMBL18654863 0.86 RIPK1 (0.37) CSNK1DCSNK1E
SCHEMBL18655240 0.84 CSNK1D (0.36) CSNK1DCSNK1ETHRBGLAUSP2
SCHEMBL18654802 0.81 ADORA2A (0.36) CSNK1DCSNK1ETHRBUSP2ALDH1A1
SCHEMBL14897228 0.78 NPC1 (0.40) CSNK1DCSNK1ETGFBR1USP2ALDH1A1
SCHEMBL14896802 0.76 NPC1 (0.39) CSNK1DCSNK1ETGFBR1USP2ALDH1A1
SCHEMBL18654415 0.75 TP53 (0.36) CSNK1DCSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2768509-B1 SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2017-03-22 — — EP disclosed
Send feedback